Pharmacogenetics : opportunities and challenges for health innovation /
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Korporativní autor: | |
| Další autoři: | , |
| Médium: | Kniha |
| Jazyk: | angličtina |
| Vydáno: |
Paris :
OECD,
2009
|
| Vydání: | [1st ed.] |
| Témata: | |
| ISBN: | 9789264076792 |
| On-line přístup: |
|
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
MARC
| LEADER | 00000aam a2200000 4500 | ||
|---|---|---|---|
| 003 | SK-BrCVT | ||
| 005 | 20220621172432.0 | ||
| 006 | a####e######000#0# | ||
| 008 | 100202s2009 fr ####e######000#0#eng d | ||
| 020 | |a 9789264076792 | ||
| 035 | |a CVTIDW1518695 | ||
| 040 | |b slo |c CVT |a CVTI SR |e AACR2 | ||
| 041 | 0 | |a eng | |
| 044 | |a fr | ||
| 080 | |a 615 |2 UDC-MRF | ||
| 080 | |a 575.1 |2 UDC-MRF | ||
| 080 | |a 616 |2 UDC-MRF | ||
| 100 | 1 | |a Caulcott, Celia |4 aut | |
| 245 | 1 | |a Pharmacogenetics : |b opportunities and challenges for health innovation / |c Written by: Celia Caulcoot, Peter Greenaway, Kees van Gool ... [et al.] ; edited by: Marilyn Smith, Lantz Miller | |
| 250 | |a [1st ed.] | ||
| 260 | |a Paris : |b OECD, |c 2009 | ||
| 300 | |a 131 s. : |b grafy, lit., tab. ; | ||
| 500 | |a OECD innovation strategy | ||
| 653 | 1 | |a farmakogenetika |a zdravotníctvo |a farmakogenomika |a klinické skúšanie |a farmaceutický priemysel | |
| 655 | 7 | |a prehľady |2 SNKPH | |
| 700 | 1 | |a Greenaway, Peter |4 aut | |
| 700 | 1 | |a Gool, Kees van |4 aut | |
| 700 | 1 | |a Smith, Marilyn |4 edt | |
| 700 | 1 | |a Miller, Lantz |4 edt | |
| 710 | 2 | |a Organisation for Economic Co-operation and Development, OECD (Paris, France) | |
| 852 | |a CVTISR |b 1 | ||
| 856 | 4 | |u http://ezproxy.cvtisr.sk/login.php?url=https://doi.org/10.1787/9789264076808-en | |
| 910 | |a BA002 |b E001628 |b A610045 | ||
| 919 | |a 978-92-64-07679-2 | ||
| 959 | |a o20 | ||
| 974 | |a rita.zubonyaiova |f Knihy | ||
| 992 | |a APH | ||
| 999 | |c 195495 |d 195495 | ||

